Acquisition

Aortech International PLC 23 August 2002 AorTech International plc Proposed BD Acquisition AorTech International plc ('AorTech' or 'Company'), the Scottish-based developer and manufacturer of cardiovascular devices, announces that it will not be proceeding with the proposed acquisition of the Critical Care business of BD (Becton Dickinson and Company). The Company announced at the time of its Preliminary Results in June that, due to certain technical issues which arose during the due diligence process, AorTech would not proceed with the transaction until those issues had been fully resolved. Upon further review of those issues, the Directors' have concluded that it would not be in the best interests of AorTech to proceed with the acquisition. Eddie McDaid, Chairman of AorTech stated: 'Due to circumstances outside our control, we are unable to conclude the transaction. It has become apparent that the technical issues, which arose during the latter part of our due diligence, could not be resolved to our satisfaction. As a result, it would not be in the interests of AorTech to proceed. 'We are continuing with the sub-contract manufacture of our TruCCOMS catheters at BD's plant in Singapore in accordance with our existing agreement.' Bill Strachan, CEO of AorTech commented: 'I am optimistic that AorTech's range of innovative technologies provides a strong platform on which to build. We have recently concluded the next phase of our rationalisation and reorganisation programme and I am pleased that one of the positive impacts of this review will be a significant reduction in the Company's cash burn. The management of the Company will continue to focus on our current technology base, particularly TruCCOMS, Elast-Eon, and the tri-leaflet heart valve which we believe can create increased value for the Company.' 23rd August 2002 ENQUIRIES: AorTech International plc Tel: 01698 746 699 Eddie McDaid, Chairman Bill Strachan, CEO Bell Lawrie White & Co Tel: 0141 221 7733 Clive Thomson / Elizabeth Kennedy College Hill Tel: 020 7457 2020 Michael Padley / Clare Warren This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings